Trident Lifeline trades higher on making additional investment in subsidiary

17 Apr 2025 Evaluate

Trident Lifeline is currently trading at Rs. 262.20, up by 2.80 points or 1.08% from its previous closing of Rs. 259.40 on the BSE.

The scrip opened at Rs. 272.00 and has touched a high and low of Rs. 278.00 and Rs. 262.20 respectively. So far 29400 shares were traded on the counter.

The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 339.00 on 05-Sep-2024 and a 52 week low of Rs. 140.05 on 29-Apr-2024.

Last one week high and low of the scrip stood at Rs. 278.00 and Rs. 248.15 respectively. The current market cap of the company is Rs. 301.51 crore.

The promoters holding in the company stood at 62.99%, while Institutions and Non-Institutions held 6.09% and 30.92% respectively.

Trident Lifeline has made an additional investment in its subsidiary -- TNS PHARMA by acquiring 10,20,000 equity shares. Consequently, the company’s total shareholding percentage in the subsidiary remains unchanged at 51%. 

Trident Lifeline is engaged in the pharmaceutical business ethical marketing in domestic as well as international market.

Trident Lifeline Share Price

288.35 0.00 (0.00%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×